IPO Trending
GLHRLSME / BSEListed

Global Longlife Hospital and Research Limited

Global Longlife Hospital and Research Limited is an NABH-accredited multi-speciality tertiary care hospital based in Ahmedabad, Gujarat, offering a wide range of healthcare services including oncology, ophthalmology, cardiology, dermatology, gynecology, spine and plastic surgery, dialysis, physiotherapy, ultrasound, and microbiology. The hospital has a capacity of 110 well-equipped beds supporting both medical and surgical specialties, and as of December 31, 2021, it is supported by 11 full-time consultants, over 30 experienced consulting doctors, 37 nurses, and more than 50 paramedical, pharmacy, corporate, and support staff, ensuring comprehensive and quality patient care.

₹140 - ₹140Open
Listed Price141.10
Listing Gain+0.79%
TimelineFixed Price IPO
Open21 Apr 2022
Close25 Apr 2022
Allotment30 Apr 2022
Listing04 May 2022

Quota Reservation Portions

Market MakerPortion: 1,76,000 shares
5.03%
Nii (hni)Portion: 16,62,000 shares
47.49%
RetailPortion: 16,62,000 shares
47.49%

Minimum Application Bracket Matrix

Retail1 lots / 1,000 shares
₹1,40,000
HNI2 lots / 2,000 shares
₹2,80,000

About the Company

Global Longlife Hospital and Research Limited is an NABH-accredited multi-speciality tertiary care hospital based in Ahmedabad, Gujarat, offering a wide range of healthcare services including oncology, ophthalmology, cardiology, dermatology, gynecology, spine and plastic surgery, dialysis, physiotherapy, ultrasound, and microbiology. The hospital has a capacity of 110 well-equipped beds supporting both medical and surgical specialties, and as of December 31, 2021, it is supported by 11 full-time consultants, over 30 experienced consulting doctors, 37 nurses, and more than 50 paramedical, pharmacy, corporate, and support staff, ensuring comprehensive and quality patient care.

Company Promoters

Mr. Sureshkumar Babulal JaniMr. Dhruv Sureshkumar Jani
Global Longlife Hospital and Research Limited IPO Details | GMP, Allotment & Financials | IPO Trending